Reactivation of methylation‐silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23728 ↗At a glance
Journal article in Molecular Carcinogenesis, 2024. Written by Wenfan Zhang and 6 co-authors. Institution: Department of Laboratory Medicine, School of Tianjin Medical Technology, Tianjin Medical University, Tianjin, China. Major MEDLINE topics: Cell Proliferation, DNA Methylation, Gene Expression Regulation, Neoplastic, Uterine Cervical Neoplasms. Cited 10 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China.
Abstract (original language)
Although aberrant methylation of PAX1 is closely associated with cervical cancer (CC), PAX1 methylation (PAX1m) and its role in CC remain to be elucidated. Here, we clarified the biological function of PAX1 in CC. First, PAX1m in ThinPrep cytologic test samples was measured via quantitative methylation‐specific PCR. The results showed that PAX1 promoter methylation levels were significantly increased in CC patients ( p < 0.001). We also found that PAX1 promoter methylation levels were positively correlated with tumor purity but negatively correlated with immune‐infiltration via public databases. Then, CRISPR‐based methylation perturbation tools (dCas9‐Tet1) were constructed to further demonstrate that DNA methylation participates in the regulation of PAX1 expression directly. Gain‐ and loss‐of‐function experiments were used to show that PAX1 overexpression restrained proliferation, migration and improved cisplatin sensitivity by interfering with the WNT/TIMELESS axis in CC cells. Additionally, Co‐immunoprecipitation assays further confirmed the interaction between PAX1 and TCF7L2. Taken together, our results suggested that a tumor suppressor role of PAX1 in CC and that CRISPR‐based PAX1 demethylation editing might be a promising therapeutic strategy for CC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Laboratory Medicine, School of Tianjin Medical Technology, Tianjin Medical University, Tianjin, China.
- Department of Human Anatomy, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
ORCID profiles: Rong Wang
Funding
- National Natural Science Foundation of China
Cite
APA
Zhang, W., Wang, H., Chen, S., Fan, X., Liu, Y., Shi, S., & Wang, R. (2024). Reactivation of methylation‐silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23728
Vancouver
Zhang W, Wang H, Chen S, Fan X, Liu Y, Shi S, et al. Reactivation of methylation‐silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23728
BibTeX
@article{Zhang2024,
author = {Zhang, Wenfan and Wang, Huixi and Chen, Shuang and Fan, Xueting and Liu, Yuqing and Shi, Shujuan and Wang, Rong},
title = {Reactivation of methylation‐silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23728}
}
EUVIMED